Aquestive Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Aquestive Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Aquestive Therapeutics Inc
Rating: 1.61625
Author: Trendlyne DVM scores

about

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...

5.58 -0.11 (-1.93%)

26.09% Fall from 52W High

3.1M

XNAS Volume

XNAS 12 Nov, 2025 4:06 PM (EST)

Not Eligible

Expensive Valuation

5.5 / 100

Technically Neutral

59.2 / 100

1Yr Price target upside is 85%

10 analysts

Aquestive Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aquestive Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...

26.09% Fall from 52W High

SWOT Analysis

Aquestive Therapeutics Inc Live Price Chart